Dr. Matt Gevaert, Founder and CEO of Kiyatec

September 2, 2014

MidlandsBiz Podcast Series’ mission is to support leadership in Giving Back, Diversity, Entrepreneurship, Continuous Education, the Knowledge Economy and the Arts.

Thanks to our Sponsors:

title= 

 

Kiyatec is a private company prioritizing the accurate ex vivo prediction of patients’ response to cancer drug treatment.  The future of clinical cancer diagnostics is to provide more accurate prediction of patient-specific response to cancer treatments.

The company was originally formed in 2005.  Recently one of only a handful of companies invited to present in the 2014 Bio Convention Innovation Zone in San Diego, CA to over 25,000 attendees.  This was an honor not only for Kiyatec, but it also draws attention to the cancer research happening in South Carolina.

 

[vimeo url=”http://vimeo.com/104849123″]